These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29483907)

  • 1. Human Properdin Opsonizes Nanoparticles and Triggers a Potent Pro-inflammatory Response by Macrophages without Involving Complement Activation.
    Kouser L; Paudyal B; Kaur A; Stenbeck G; Jones LA; Abozaid SM; Stover CM; Flahaut E; Sim RB; Kishore U
    Front Immunol; 2018; 9():131. PubMed ID: 29483907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Properdin Modulates Macrophage:
    Al-Mozaini MA; Tsolaki AG; Abdul-Aziz M; Abozaid SM; Al-Ahdal MN; Pathan AA; Murugaiah V; Makarov EM; Kaur A; Sim RB; Kishore U; Kouser L
    Front Immunol; 2018; 9():533. PubMed ID: 29867915
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary surfactant protein SP-D opsonises carbon nanotubes and augments their phagocytosis and subsequent pro-inflammatory immune response.
    Pondman KM; Paudyal B; Sim RB; Kaur A; Kouser L; Tsolaki AG; Jones LA; Salvador-Morales C; Khan HA; Ten Haken B; Stenbeck G; Kishore U
    Nanoscale; 2017 Jan; 9(3):1097-1109. PubMed ID: 27991644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes.
    Pondman KM; Pednekar L; Paudyal B; Tsolaki AG; Kouser L; Khan HA; Shamji MH; Ten Haken B; Stenbeck G; Sim RB; Kishore U
    Nanomedicine; 2015 Nov; 11(8):2109-18. PubMed ID: 26169151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages.
    Pondman KM; Sobik M; Nayak A; Tsolaki AG; Jäkel A; Flahaut E; Hampel S; Ten Haken B; Sim RB; Kishore U
    Nanomedicine; 2014 Aug; 10(6):1287-99. PubMed ID: 24607938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway.
    Kouser L; Abdul-Aziz M; Tsolaki AG; Singhal D; Schwaeble WJ; Urban BC; Khan HA; Sim RB; Kishore U
    Mol Immunol; 2016 May; 73():76-87. PubMed ID: 27060503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
    van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
    Front Immunol; 2019; 10():2097. PubMed ID: 31552043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T Cells.
    Pondman KM; Tsolaki AG; Paudyal B; Shamji MH; Switzer A; Pathan AA; Abozaid SM; Ten Haken B; Stenbeck G; Sim RB; Kishore U
    J Biomed Nanotechnol; 2016 Jan; 12(1):197-216. PubMed ID: 27301184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis.
    Kemper C; Mitchell LM; Zhang L; Hourcade DE
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9023-8. PubMed ID: 18579773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properdin: emerging roles of a pattern-recognition molecule.
    Kemper C; Atkinson JP; Hourcade DE
    Annu Rev Immunol; 2010; 28():131-55. PubMed ID: 19947883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterisation of the thrombospondin type I repeats of human properdin.
    Perdikoulis MV; Kishore U; Reid KB
    Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the innate immune system with carbon nanotubes.
    Pondman KM; Salvador-Morales C; Paudyal B; Sim RB; Kishore U
    Nanoscale Horiz; 2017 Jul; 2(4):174-186. PubMed ID: 32260639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.
    Varghese PM; Mukherjee S; Al-Mohanna FA; Saleh SM; Almajhdi FN; Beirag N; Alkahtani SH; Rajkumari R; Nal Rogier B; Sim RB; Idicula-Thomas S; Madan T; Murugaiah V; Kishore U
    Front Immunol; 2021; 12():747654. PubMed ID: 34956182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon nanotubes stimulate synovial inflammation by inducing systemic pro-inflammatory cytokines.
    Ma J; Li R; Qu G; Liu H; Yan B; Xia T; Liu Y; Liu S
    Nanoscale; 2016 Oct; 8(42):18070-18086. PubMed ID: 27714147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells.
    Murphy FA; Schinwald A; Poland CA; Donaldson K
    Part Fibre Toxicol; 2012 Apr; 9():8. PubMed ID: 22472194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of a family of tick-derived complement inhibitors targeting properdin.
    Braunger K; Ahn J; Jore MM; Johnson S; Tang TTL; Pedersen DV; Andersen GR; Lea SM
    Nat Commun; 2022 Jan; 13(1):317. PubMed ID: 35031611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
    Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J
    Front Immunol; 2020; 11():1643. PubMed ID: 32849563
    [No Abstract]   [Full Text] [Related]  

  • 18. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
    Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
    J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells.
    van Essen MF; Schlagwein N; van den Hoven EMP; van Gijlswijk-Janssen DJ; Lubbers R; van den Bos RM; van den Born J; Ruben JM; Trouw LA; van Kooten C;
    Eur J Immunol; 2022 Apr; 52(4):597-608. PubMed ID: 35092629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation by carbon nanotubes.
    Rybak-Smith MJ; Sim RB
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1031-41. PubMed ID: 21669239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.